Iovance Biotherapeutics Inc. buy ShareholderRisk40
Start price
24.03.26
/
50%
€3.08
Target price
24.04.26
€3.00
Performance (%)
-5.64%
End price
25.04.26
€2.91
Summary
This prediction ended on 25.04.26 with a price of €2.91. With a performance of -5.64%, the BUY prediction for Iovance Biotherapeutics Inc. by ShareholderRisk40 closed slightly in the red. ShareholderRisk40 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -4.188% | -4.188% |
| iShares Core DAX® | 0.985% | 8.314% |
| iShares Nasdaq 100 | 2.067% | 16.765% |
| iShares Nikkei 225® | 2.270% | 15.605% |
| iShares S&P 500 | 1.043% | 11.077% |
Comments by ShareholderRisk40 for this prediction
In the thread Trading Lion Biotechnologies Inc
Die von ShareholderRisk40 gewählte maximale Laufzeit wurde überschritten